Latest from NELLPC

Friday Letter 08/02/2019

FMD Advice Notice

Please see the following FMD Advice notice from NHS England, published 7th February 2019.

The Falsified Medicines Directive (FMD) will apply from tomorrow, 9th February 2019, please make sure understand what is expected of you and are working towards compliance.

Please read the following letter in full and see the links below for further support

Implementing the Falsified Medicines Directive: Safety Features | GOV.UK

FMD compliance – guidance from the UK FMD Working Group | PSNC

Who’s responsible for FMD? |RPS

In preparation for FMD compliance, please read the following article from the Royal Pharmacietical Society.

Who’s responsible for FMD- Falsified Medicines Directive |RPS

NHS Long Term Plan

This is the most easy read version of the most important document that is going to affect our working lives.

The NHS Long Term Plan was developed in partnership with those who know the NHS best – frontline health and care staff, patients and their families and other experts.

The development of Primary Care Networks will seriously affect the way we work and the concept requires some thought and understanding to optimise your chances of joint working with newly configured MDTs.

Foundation Pharmacist Role Analysis | Royal Pharmaceutical Society

Please see the following message from RPS, give your opinion support by completing the short questionnaire.

Thank you

Foundation Pharmacist Role Analysis

Shape the future training and development of foundation pharmacists across the UK!

The Royal Pharmaceutical Society and Health Education England are analysing the roles of pharmacists in the early years of their careers.  RPS will use the analysis to guide the design and review of a UK wide Foundation Pharmacist Framework.  The framework will test skills and capabilities at the point of entry, during development and upon completion of training programmes. 

HEE will use the analysis to inform the pharmacy education and training review which is currently underway.

In the first phase of the role analysis, we gathered a broad spectrum of views and evidence. We are now seeking wider feedback on the identified criteria for the core skills, knowledge and behaviours included in the draft framework. 

We greatly value your input and contribution into this important work.

The questionnaire  will be available for completion until Thursday 28th February 2019 and will take approximately 20 minutes to complete. 

Information you provide will remain anonymous and your contribution will be kept confidential, with responses reported at the group level in final reports.

For help and comments please contact Emma-Louise Rowe on

Drug costs and doctors

A document from BMJ Open states finds the following.


Doctors in dispensing practices are more likely to prescribe higher cost drugs. This is the largest study ever conducted on dispensing practices, and the first contemporary research suggesting some UK doctors respond to a financial conflict of interest in treatment decisions. The reimbursement system for dispensing practices may generate unintended consequences. Robust routine audit of practices prescribing higher volumes of unnecessarily expensive drugs may help reduce costs.

Reminder: National Campaign- Help us Help you

We hope you are all actively participating in the National Campaign launched Monday, Help us Help you- Before it gets worse.

Be reminded that this campaign is the first of the six national campaigns for 2019/2020 that all pharmacies MUST participate in as part of the CPCF.

You should have already received your resources from NHS England, please click here for more information on the campaign and further resources to support your participation.

If you have any queries or concerns, please contact the LPC office.

Reminder: Further vaccine ordering guidance for 2019/2020

Please be reminded that NHS England issued an update further to their ordering guidance letter for 2019/2020 that was published late last year.

Click here for more information

Primary care immunisation update webinar series – a free training resource for immunisers in London | PHE

Free training resource for Immunisers in London from Public Health England, please see below the flyer with the dates and links to register.

2019 RPS/UCL School of Pharmacy New Year Lecture on the Treatment and Prevention of Diabetes | UCL

Click here to view the article

Polypharmacy: Getting our medicines right | RPS

Click here to view the full article

Obesity-related cancers rise for younger US generations, study says | BBC

Click here for the full article

Class 4 Drug Alert: Amoxicillin 500mg Capsules BP (MDR 92-12/18)

A change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline. The change concerns the addition of the symptoms of a potential side effect, ‘Drug Reaction with Eosinophilia and Systemic Symptoms’ (DRESS).

Please see the affected product details and a brief description of what is required below. Ensure you read the full alert before taking action.

Company name

Accord Healthcare Limited

Product description

Amoxicillin 500mg Capsules

PL 20075/0264

Batch number   Expiry date         Pack size              First distributed

MP 18062             01/ 2021               1 x 21                     04 Oct 2018

MP 18063             01/ 2021               1x 1 x 21               26 Oct 2018

MP 18064             01/ 2021               1x 1 x 21               16 Oct 2018

Advice for healthcare professionals

When dispensing this product, please check the Marketing Authorisation Holder and the batch number. If any of the above batch numbers are being dispensed, please remove the PIL in the pack and provide a copy of the correct version, which can be downloaded from the link below:

Please see the full alert and take the appropriate action

Leave a Reply

Scroll To Top

This website uses cookies to give you the best experience. Please click the 'Accept' button to agree to the use of these cookies in accordance with our Cookie Policy and to close this bar.

For more information on the cookies we use, please see our Cookie Policy.

You can revoke your consent and edit your preferences at any time using the links in the website footer.
Cookie Policy